Jean-Francois Hamel's Biography

• Home
• |
• Register
• |
• Submissions
  • Submission Guidelines
  • Submissions
• |
• Agenda
  • Keynote Speakers
  • Agenda Day 1
  • Agenda Day 2
• |
• Exhibition
• |
• Venue
• |
• Media
  • Media Partners
• |
• Short Courses
  • Business Courses
  • Workshops
• |

A Novel Approach to Early Process Design of Therapeutic Monoclonal Antibody Production in CHO Cells Using an Optically-Based Single-Use Mini-Bioreactor Technology

Thursday, 28 June 2012 at 14:45

Add to Calendar ▼2012-06-28 14:45:002012-06-28 15:45:00Europe/LondonA Novel Approach to Early Process Design of Therapeutic Monoclonal Antibody Production in CHO Cells Using an Optically-Based Single-Use Mini-Bioreactor TechnologySELECTBIOenquiries@selectbiosciences.com

This study proposes an innovative early optimization process for biosimilar monoclonal antibodies (mAb) that combines optically-based mini-bioreactor and lectin array-based glycoanalytical technologies to optimize (mAb) titer and glycosylation, in parallel.